Found 19 matching trials
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors PHASE4 Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Show More Location
Kurume University Hospital
Learn More & Join Trial
SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity NA Obesity is closely associated with an increased risk of cardiomyopathy beca...
Show More Location
National Cheng Kung University Hospital
Learn More & Join Trial
Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV. NA The high prevalence of prediabetes in HIV patients is also an outpost event...
Show More Location
Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV: A Randomized Controlled Trial.
Learn More & Join Trial
SGLT2 Inhibitors in Patients With PCOS PHASE4 Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with a pre...
Show More Location
Shanghai Tenth People' Hospital
Learn More & Join Trial
A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea PHASE3 The purpose of this study is to assess the safety, tolerability, and effica...
Show More Location
Multiple Locations
Learn More & Join Trial
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan PHASE4 This study aims to determine if the addition of Canagliflozin (Invokana™) t...
Show More Location
University Hospitals of Leicester NHS Trust
Learn More & Join Trial
Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP) PHASE3 Type 2 diabetes is associated with diabetic cognopathy, the prevalence of A...
Show More Learn More & Join Trial
Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome PHASE4 The goal of this clinical trial is to investigate the use of ultra-high per...
Show More Location
Multiple Locations
Learn More & Join Trial
Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease NA Type 2 diabetes mellitus (T2DM) is always accompanied with nonalcoholic fat...
Show More Location
Multiple Locations
Learn More & Join Trial
SGLT2 Inhibitor Utilization Re-perfusion Therapy PHASE4 Background:
Reperfusion therapies, including intravenous rt-PA and mechani...
Show More Location
Multiple Locations
Learn More & Join Trial